P G De Benedetti

Ab initio modeling and molecular dynamics simulation of the alpha 1b-adrenergic receptor activation.

A. Scheer, F. Fanelli, P. D. De Benedetti, 1998, Methods.

Amino acids of the α 1B‐adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes

F. Fanelli, P. D. De Benedetti, A. Cavalli, 1996, FEBS letters.

Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.

M. Hamon, M. Menziani, É. Doucet, 1999, Journal of medicinal chemistry.

Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.

M. Menziani, P. D. De Benedetti, A. Cappelli, 1996, Journal of medicinal chemistry.

Relevance of theoretical molecular descriptors in quantitative structure-activity relationship analysis of alpha1-adrenergic receptor antagonists.

M. Karelson, M. Menziani, P. D. De Benedetti, 1999, Bioorganic & medicinal chemistry.

Electrostatic analysis and Brownian dynamics simulation of the association of plastocyanin and cytochrome f.

R C Wade, R. Wade, R. Gabdoulline, 2001, Biophysical journal.

Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.

T. Langer, M. Hamon, M. Menziani, 1998, Journal of medicinal chemistry.